More Analyses are Needed to Evaluate the Effectiveness of Protection by Vaccines and Previous Infection Against the Omicron Variant of SARS-CoV-2
- PMID: 35763367
- PMCID: PMC9384435
- DOI: 10.1093/infdis/jiac257
More Analyses are Needed to Evaluate the Effectiveness of Protection by Vaccines and Previous Infection Against the Omicron Variant of SARS-CoV-2
Conflict of interest statement
Potential conflict of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
Comment in
-
Response to Beran et al.J Infect Dis. 2022 Sep 13;226(5):944-945. doi: 10.1093/infdis/jiac259. J Infect Dis. 2022. PMID: 35763416 No abstract available.
Comment on
-
Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2.J Infect Dis. 2022 Oct 17;226(8):1385-1390. doi: 10.1093/infdis/jiac161. J Infect Dis. 2022. PMID: 35482442 Free PMC article.
References
-
- Berec L, Šmíd M, Přibylová L, et al. Real-life protection provided by vaccination, booster doses and previous infection against COVID-19 infection, hospitalisation or death over time in the Czech Republic: a whole country retrospective view. medRxiv, doi: 2021.12.10.21267590, 12 December 2021, preprint: not peer reviewed.
-
- Ministry of Health . COVID-19 v ČR: Otevřené datové sady a sady ke stažení (COVID-19 in the Czech Republic: Open datasets and sets to download). [in Czech]. https://onemocneni-aktualne.mzcr.cz/api/v2/covid-19. Accessed 20 January 2022.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
